European Companies Search Engine

EU funding (€5,974,238): ERA-NET on cardiovascular diseases to implement joint transnational research projects and set up international cooperations Hor 1 Oct 2015 EU Research and Innovation programme "Horizon"

Overview

Text

ERA-NET on cardiovascular diseases to implement joint transnational research projects and set up international cooperations

Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite the overall burden of CVD on European citizens and national health systems, translational cardiovascular research is fragmented and mainly occurs at national levels. However, the present and future challenges in cardiovascular research can only be met by an effective cooperation at transnational level. Therefore, the proposed European Research Area Network on cardiovascular diseases (ERA-CVD) aims to coordinate national and regional programmes for translational research in the area CVD by implementing one Joint Transnational Call (JTC2016) with EU Co-funding followed by further non-co-funded JTC (2017-2019). Although this consortium will be newly established, a collaboration and alignment of national programmes and activities has already been achieved during the preparation of the ERA-Net Co-fund proposal. This process is supported by CardioScape an EU-funded survey of the European cardiovascular research landscape coordinated by the European Society of Cardiology (ESC). The current ERA-CVD proposal will extend and strengthen the transnational cooperation of the current 23 ministries/institutions/foundations from 18 European, associated and third countries. Furthermore, ERA-CVD plans to cooperate with the ESC and the European Heart Network (EHN). Moreover, the collaboration with European Research Infrastructures, e.g. the ESFRI-initiatives is intended in order to set up an efficient European framework for innovative transnational research on CVD. Also the extension of the consortium and international collaborations are intended.


Funded Companies:

Company name Funding amount
Agence Nationale de la Recherche €802,313
Bundesministerium Fuer Forschung Technologie UND Raumfahrt €1,137,675
Deutsches Zentrum FUR Luft - UND Raumfahrt e. V. €23,925
Fonds de la Recherche Scientifique- FNRS €134,063
Fonds Voor Wetenschappelijk Onderzoek-Vlaanderen €134,063
Fonds ZUR Förderung DER Wissenschaftlichen Forschung €245,438
Fundacao para A Ciencia e A Tecnologia €208,313
Instituto de Salud Carlos III €245,438
Ministerio da Saude €96,938
Ministero Della Salute €616,688
Ministerul Educatiei si Cercetarii €171,188
Ministrstvo za Izobrazevanje, Znanost in Sport €137,775
Ministry OF Health €148,913
Narodowe Centrum Badan i Rozwoju €245,438
Nasjonalforeningen FOR Folkehelsen €67,650
National Science AND Technology Council €0.00
Nederlandse Hartstichting €431,063
Norges Forskningsrad €245,438
SA Eesti Teadusagentuur €96,938
Slovenska Akademia Vied €104,363
Turkiye Bilimsel VE Teknolojik Arastirma Kurumu €356,813
Valsts Izglitibas Attistibas Agentura €171,188
Zorgonderzoek Nederland ZON €152,625

Source: https://cordis.europa.eu/project/id/680969

The filing refers to a past date, and does not necessarily reflect the current state.